TOVX logoTheriva Biologics, Inc. (TOVX) — Estimates & Forecasts

Proprietary EPS, revenue & margin forecasts — FY+1 to FY+4

Popular:

Theriva Biologics, Inc. (TOVX)

View Full Profile →